• Granted inducement stock options covering 380,575 shares to two new hires under its 2026 Inducement Plan.
• Included an option for 275,000 shares for newly appointed Chief Legal Officer Gregory Shiferman.
• Options carry a $23.42 exercise price, set at the Sept. 1 Nasdaq close.
• Vesting starts with 25% after one year, then in 12 equal quarterly installments, subject to continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bicara Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609030830PRIMZONEFULLFEED9820564) on September 03, 2026, and is solely responsible for the information contained therein.